Skip to main content
. 2022 Jun 20;10(6):1455. doi: 10.3390/biomedicines10061455
BMI Body mass index
FPG Fasting plasma glucose
HbA1c Hemoglobin A1c
HR Hazard ratio
HOMA-IR Homeostatic Model Assessment for Insulin Resistance
IGT Impaired glucose tolerance
IR Incidence rate
IRR Incidence rate ratio
NGT Normal glucose tolerance
NS Not significant
N/A Not available
OGTT Oral glucose tolerance test,
PCOS Polycystic ovary syndrome
PreDM Prediabetes
PY Person-years
T2D Type 2 diabetes